Page last updated: 2024-08-23

bromocriptine and Encephalitis Lethargica Type Parkinsonism

bromocriptine has been researched along with Encephalitis Lethargica Type Parkinsonism in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fischer, PA; Majer, M; Przuntek, H; Welzel, D1
Bouchard, S; Grimes, JD; Jones, MW; Kofman, OS; Molina-Negro, P1
Caraceni, T; Giovannini, P; Girotti, F; Parati, E; Pederzoli, M; Scigliano, G1
Lees, AJ; Shaw, KM; Stern, GM1
Alves, RS; Barbosa, ER; Scaff, M1
Kadykov, AS; Pivovarova, VM; Shvedkov, VV; Stoliarova, LG1

Trials

2 trial(s) available for bromocriptine and Encephalitis Lethargica Type Parkinsonism

ArticleYear
[Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
    Deutsche medizinische Wochenschrift (1946), 1984, Aug-24, Volume: 109, Issue:34

    Topics: Aged; Benserazide; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Random Allocation; Time Factors

1984
Bromocriptine (ParlodelR) in the treatment of Parkinson's disease.
    Progress in neuro-psychopharmacology & biological psychiatry, 1982, Volume: 6, Issue:4-6

    Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic

1982

Other Studies

4 other study(ies) available for bromocriptine and Encephalitis Lethargica Type Parkinsonism

ArticleYear
"Long term evaluation of combined treatment of Parkinson disease with L-dopa, peripheral decarboxylase inhibitors and bromocreptine".
    Italian journal of neurological sciences, 1981, Volume: 2, Issue:4

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic

1981
Bromocriptine and thyroid-stimulating-hormone secretion.
    Lancet (London, England), 1977, Nov-26, Volume: 2, Issue:8048

    Topics: Bromocriptine; Depression, Chemical; Humans; Parkinson Disease, Postencephalitic; Thyrotropin; Thyrotropin-Releasing Hormone

1977
Postvaccinal parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:2

    Topics: Bromocriptine; Child, Preschool; Dose-Response Relationship, Drug; Encephalomyelitis, Acute Disseminated; Humans; Levodopa; Magnetic Resonance Imaging; Male; Measles Vaccine; Neurologic Examination; Parkinson Disease, Postencephalitic; Substantia Nigra

1992
[Experience with the use of parlodel in the treatment of Parkinson patients].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1986, Volume: 86, Issue:2

    Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Hypoxia, Brain; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary

1986